万维提示：
1、该刊只有国际刊号。
2、投稿方式：官网投稿。
3、官网网址（中华医学期刊网信息）：
https://jnmmi.theimms.com/（投稿）
https://www.yiigle.com/Journal/JNMMI
4、官网电话：0510-6808883
5、官网邮箱：jnmmi@cmaph.org
6、出刊日期：季刊，一年出版四期。
7、官网信息：2025-2027年免收文章处理费。
2025年12月31日星期三
Instructions for Authors
【官网信息】
About the Journal
The Journal of Nuclear Medicine and Molecular Imaging (JNMMI), the official journal of the Chinese Society of Nuclear Medicine, is an international, peer-reviewed, open-access journal dedicated to advancing research and clinical applications in nuclear medicine and molecular imaging. Launched in September 2025, JNMMI is published quarterly (64 pages per issue) in English, available in both print and online formats. The journal serves as a platform for scholars, clinicians, and industry professionals to share cutting-edge discoveries and innovations, fostering interdisciplinary dialogue to accelerate the translation of scientific breakthroughs into clinical practice, particularly in oncology, cardiology, neurology, and related fields. The journal allows free access to its contents and permits authors to self-archive the final accepted version of the articles on any OAI-compliant institutional/subject-based repository.
Scope of the Journal
JNMMI welcomes high-quality submissions in nuclear medicine and molecular imaging, including:
Clinical applications and translational studies in nuclear medicine.
Basic research in radiopharmaceuticals and molecular imaging.
Development and preclinical/clinical validation of novel molecular probes.
Advances in nuclear imaging technology and equipment, with emphasis on clinical significance.
Types of Manuscripts
JNMMI welcomes the following types of manuscripts:
Original Research: Includes experimental studies, clinical research, and epidemiological studies (up to 5,000 words, excluding abstract, references, and tables).
Structured abstract (300 words): Background, Methods, Results, Conclusions.
3–6 keywords.
Approximately 30 references, preferably from the last 5 years.
Review Article: Systematic reviews on current techniques, therapies, clinical trials, or emerging research (up to 5,000 words excluding tables, references and abstract for standard reviews, with up to 90 references; 20,000–30,000 words for comprehensive reviews, with up to 350 references).
Indicative abstract (150–250 words).
3–6 keywords.
Systematic reviews must include a methods section (data location, selection, extraction, and synthesis).
Interesting Cases: Reports of unique or noteworthy clinical cases demonstrating innovative applications of nuclear medicine and molecular imaging (up to 1,000 words).
Concise descriptive summary with a representative image.
3–6 keywords.
Up to 5 references, 2 tables or figures.
Declaration of patient consent if patient information is included.
Guidelines and Consensus: Articles that present or analyze current clinical practice guidelines, consensus statements, or best practices in the field (flexible length based on organizational standards).
Abstract (150–250 words) describing development, recommendations, and scope.
3–6 keywords.
Include a concise table or graphic summarizing key points.
Editorials: Invited opinion articles, academic discussions, and special commentaries (up to 2,000 words).
Up to 25 references.
No abstract or keywords.
The Editorial Process
Manuscripts are reviewed with the understanding that they are submitted exclusively to JNMMI, have not been published elsewhere, and are not under consideration elsewhere. The editorial process includes:
Initial Screening: Editors assess manuscripts for originality, scientific quality, and relevance to nuclear medicine and molecular imaging. Manuscripts lacking novelty, with serious flaws, or not aligned with JNMMI’s scope may be rejected before peer review.
Peer Review: JNMMI employs a single-blind peer review process (reviewers know authors’ identities, but authors do not know reviewers’ identities). Manuscripts are evaluated based on:
Novelty and scientific quality.
Rigor of experimental design and reliability of results.
Clarity of structure and writing.
Comprehensive discussion of existing literature.
The review process typically takes 6–8 weeks, depending on reviewer availability and manuscript volume.
Revisions: Authors receive reviewers’ comments and must submit a point-by-point response with revisions. Changes should be marked (e.g., underlined or colored text).
Copy Editing: Accepted manuscripts undergo copy editing for grammar, punctuation, and format. Page proofs are sent to the corresponding author, who must return corrections within 7 days.
Online Publication: Accepted articles are published online as “Ahead of Print” to ensure rapid dissemination, aligned with the journal’s quarterly schedule (64 pages per issue).
Submission Instructions
All manuscripts must be submitted via the JNMMI online submission system (https://jnmmi.theimms.com). Authors must register on the website and use their account to track submissions. Submissions should include:
File Format: Manuscripts must be in Microsoft Word (.doc/.docx).
Title Page: Include:
Manuscript type and title.
Full names, affiliations, and contact details of all authors.
Corresponding author’s name, email, and phone number.
Word counts for abstract and main text (excluding references, tables, and figures).
Funding sources, acknowledgments, and conflict of interest disclosures.
Statement confirming all authors have read and approved the manuscript.
Details of prior presentations or related submissions.
Author contributions (e.g., concept, design, data analysis, manuscript preparation).
Abstract and Keywords:
Original Articles: Structured abstract (300 words: Background, Methods, Results, Conclusions).
Review Articles: Indicative abstract (150–250 words).
Interesting Cases: Descriptive summary with a representative image.
Guidelines and Consensus: Abstract describing development, recommendations, and scope.
3–6 keywords for all manuscripts.
Images: Submit as JPEG or TIFF files at 300 PPI (minimum 1800 × 1600 pixels). Include legends (up to 40 words) at the end of the manuscript file.
Appendices: Include additional experimental data or technical details as supplementary materials.
Copyright Transfer Form: Submit a signed form from all authors as a scanned image via the submission system (https://jnmmi.theimms.com).
File Size Limit: Maximum 100 MB per uploaded file.
Manuscripts not adhering to these guidelines will be returned for correction before review.
Preparation of Manuscripts
Manuscripts must follow the “International Committee of Medical Journal Editors (ICMJE) Recommendations” and JNMMI’s specific requirements:
Language: Use American English consistently.
Font and Formatting: Use 11-point font, double-spaced, with page numbers at the bottom.
Abbreviations: Write out abbreviations in full at first use in the title, abstract, figure, and table.
Numerals: Spell outnumbers1–10 and all numbers at the start of sentences.
Structure for Original Articles:
Abstract: Structured (Background, Methods, Results, Conclusions; 300 words).
Introduction: State purpose and rationale, citing pertinent references.
Methods:
Describe participant selection, eligibility/exclusion criteria, and source population.
Detail methods, apparatus (with manufacturer details), and procedures for reproducibility.
Reference established methods; describe new or modified methods with justifications.
Specify drugs/chemicals (generic names, doses, routes).
For clinical trials, follow CONSORT guidelines and include trial registration details.
For ethical considerations, confirm compliance with the Declaration of Helsinki (2024 revision) for human studies or ARRIVE 2.0/AVMA guidelines (2020) for animal studies. Include ethics committee approval and informed consent details.
Statistics: Quantify findings wherever possible and include appropriate measures of uncertainty (e.g., confidence intervals). Report any losses to observation (e.g., dropouts). Specify the statistical methods used in the Results section. Avoid non-technical use of statistical terms such as “random,” “normal,” “significant,” “correlation,” and “sample.” Define all statistical terms, abbreviations, and symbols. Specify the software used. Use uppercase italics for P values (e.g., P = 0.048), and report exact P values. Present confidence intervals for mean differences, proportions, odds ratios, and hazard ratios.
Results: Present findings logically, emphasizing key results without repeating table/figure data. Include absolute numbers and statistical methods used.
Discussion: Summarize key findings, strengths, limitations, implications, controversies, and future directions. Avoid repeating Introduction/Results or claiming priority for incomplete work.
References: Approximately 30 for original articles, up to 350 for comprehensive reviews, with most from the last 5 years.
Tables: Number consecutively, provide brief titles, and place after references. Use footnotes following this sequence of symbols: *, †, ‡, §, ||, ¶, **, ††, ‡‡. Obtain permission for borrowed/adapted tables.
Figures: Number consecutively, ensure 300 PPI resolution, and provide legends (up to 40 words). Submit numerical data for graphs. Obtain permission for previously published figures.
Patient Privacy: Remove identifying information unless essential, with written informed consent. Include a consent statement in the manuscript if applicable.
References
Follow the Vancouver style with DOIs where available. Number references consecutively in the order they appear in the text, using superscript Arabic numerals after punctuation. Abbreviate journal titles per Index Medicus. List up to 6 authors; for more, use “et al.”. Avoid citing abstracts, unpublished observations, or personal communications unless essential.
Examples:
Journal: Meng FG, Jia FM, Ren XH, Ge Y, Wang KL, Ma YS, et al. Vagus Nerve Stimulation for Pediatric and Adult Patients with Pharmaco-resistant Epilepsy. Chin Med J 2015;128:2599–2604. doi: 10.4103/0366-6999.166023.
Book: Weinstein L, Swartz MN. Pathogenic properties of invading microorganisms. In: Sodeman WA Jr., Sodeman WA, eds. Pathologic physiology: mechanisms of disease. Philadelphia: Saunders; 1974:457–472.
Electronic Source: Cumulative number of reported cases of severe acute respiratory syndrome (SARS). Geneva: World Health Organization, 2003. Available from: http://www.who.int/csr/sarscountry/2003_04_04/en/. [Last accessed on 2003 April 9].
Clinical Trial Registry
JNMMI requires registration of clinical trials. JNMMI will consider publishing clinical trials that have been registered with a clinical trial registry that allows free online access to the public. Registration in the following trial registers is acceptable: http://www.chictr.org.cn/; http://www.ctri.in/; http://www.clinicaltrials.gov/; http://www.isrctn.org/; http://www.trialregister.nl/trialreg/index.asp; and http://www.umin.ac.jp/ctr and any registry that is a primary register of the WHO International Clinical Trials Registry Platform (ICTRP; www.who.int/ictrp/network/primary/en/index.html).
Data Sharing
Authors must include a data sharing statement indicating:
Whether individual deidentified participant data (including data dictionaries) will be shared.
The data in particular will be shared.
Availability of related documents (e.g., study protocol).
Data availability period and access criteria.
If no additional data are available, state: “Data sharing: no additional data available.”
See ICMJE guidelines (http://www.icmje.org/news-and-editorials/data_sharing_june_2017.pdf) and DataCite (https://www.datacite.org/) for repositories.
Authorship Criteria
Per ICMJE Recommendations, authorship requires:
Substantial contributions to conception/design, data acquisition, analysis, or interpretation.
Drafting or critically revising the manuscript.
Final approval of the published version.
Accountability for all aspects of the work.
General supervision, funding acquisition, or data collection alone does not qualify. The corresponding author is responsible for communication and revisions. Changes to authorship (order, addition, deletion) require written consent from all authors.
Conflicts of Interest
Authors must disclose financial or personal relationships that could influence the research, including affiliations with products or institutions mentioned in the manuscript. Include a conflict of interest statement on the title page.
Ethical Guidelines
Human Studies: Comply with the Declaration of Helsinki (2024 revision). Provide ethics committee approval and informed consent (or assent for children >7 years, per regional guidelines). Ensure patient confidentiality.
Animal Studies: Follow ARRIVE 2.0 and AVMA Guidelines (2020) for anesthesia/euthanasia.
Consent for Publication: Obtain written informed consent for identifiable patient information or images. Authors must archive consent forms.
Unethical Research: Manuscripts reporting unethical research will not be considered.
Retraction Policy
JNMMI may retract articles for:
Unreliable findings (misconduct or honest error).
Redundant publication without proper reference.
Plagiarism.
Unethical research.
JNMMI follows COPE Retraction Guidelines (http://publicationethics.org/files/retraction%20guidelines_0.pdf).
Article Processing Charges (APC)
Upon acceptance, authors must pay an APC:
Authors from China: CHY 1,600 per page (based on final PDF), plus CHY 1,000 for color figures.
Authors outside China: USD 320 per page (including all figures).
Please note: The APC for papers published from 2025 to 2027 will be fully sponsored by the Affiliated Hospital of Jiangnan University.
Copyright and Licensing
Upon acceptance, copyright transfers to JNMMI. Authors retain rights for academic use with proper attribution. As an open-access journal, articles are freely accessible worldwide.
Checklist for Submission
Covering Letter: Signed by all authors, mentioning prior publications/presentations, funding, and conflicts of interest.
Authors: Full names, affiliations, and corresponding author details provided. Identity not revealed in blinded manuscript file.
Format: 11-point font, page numbers, structured abstract (if applicable), 3–6 keywords, Vancouver-style references, no tracked changes.
Language: American English, full terms for abbreviations at first use, numerals 1–10 spelled out.
Tables/Figures: No data duplication, good quality (300 PPI), legends provided, permissions for borrowed material.
Ethics: Ethics committee approval, informed consent, and patient privacy maintained.
Copyright Form: Signed by all authors.
Contact Information
Editorial Office:
Email: jnmmi@cmaph.org
Website: under construction
Phone: +86 510 6808 8838
Additional Notes
JNMMI reserves the right to edit manuscripts for clarity and readability, consulting authors for major changes. Each issue is limited to 64 pages, so early submission is encouraged to secure space in the quarterly publication schedule. For further guidance, refer to:
ICMJE: http://www.icmje.org
EQUATOR Network: http://www.equator-network.org
COPE: http://publicationethics.org
